Functional magnetic resonance imaging monitoring of pathological changes in rodent livers during hyperoxia and hypercapnia

Hepatology

Volumn 48, Issue 4, 2008, Pages 1232-1241

  Barash, Hila ^a   Gross, Eitan ^a   Edrei, Yifat ^a   Pappo, Orit ^a   Spira, Gadi ^b   Vlodavsky, Israel ^b   Galun, Eithan ^a   Matot, Idit ^a,c   Abramovitch, Rinat ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEMODYNAMICS; HISTOPATHOLOGY; HYPERCAPNIA; HYPEROXIA; HYPOVOLEMIA; IMAGE ANALYSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER HEMORRHAGE; LIVER PERFUSION; LIVER REGENERATION; MALE; MOUSE; NON INVASIVE PROCEDURE; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; ANIMAL; BIOLOGICAL MODEL; BLEEDING; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; GENETICS; LIVER; LIVER CIRRHOSIS; LIVER RESECTION; METABOLISM; MOUSE MUTANT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; SPRAGUE DAWLEY RAT; VASCULARIZATION;

GLYCOPROTEIN P; P GLYCOPROTEIN 2; P-GLYCOPROTEIN 2; THIOACETAMIDE;

ANIMALS; DISEASE MODELS, ANIMAL; HEMORRHAGE; HEPATECTOMY; HYPERCAPNIA; HYPEROXIA; LIVER; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; P-GLYCOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY; THIOACETAMIDE;

EID: 54449087433     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22394     Document Type: Article

References (45)

1. Manos MM, Leyden WA, Murphy RC, Terrault NA, Bell BP. Limitations of conventionally derived chronic liver disease mortality rates: Results of a comprehensive assessment. HEPATOLOGY 2008;47:1150-1157.
2. Nguyen GC, Thuluvath PJ. Racial disparity in liver disease: Biological, cultural, or socioeconomic factors. HEPATOLOGY 2008;47:1058-1066.
3. Nord HJ. Biopsy diagnosis of cirrhosis: Blind percutaneous versus guided direct vision techniques-a review. Gastrointest Endosc 1982;28:102-104.
4. Garcia-Tsao G, Boyer JL. Outpatient liver biopsy: How safe is it? Ann Intern Med 1993;118:150-153.
5. Piccinino F, Sagnelli E, Pasquale G, Giusti G. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 1986;2:165-173.
6. Friedman SL. Liver fibrosis-from bench to bedside. J Hepatol 2003; 38(Suppl 1):S38-S53.
7. Assy N, Minuk GY. Liver regeneration: Methods for monitoring and their applications. J Hepatol 1997;26:945-952.
8. Vauthey JN. Liver imaging. A surgeon's perspective. Radiol Clin North Am 1998;36:445-457.
9. Hockings PD, Roberts T, Campbell SP, Reid DG, Greenhill RW, Polley SR, et al. Longitudinal magnetic resonance imaging quantitation of rat liver regeneration after partial hepatectomy. Toxicol Pathol 2002;30:606-610.
10. Chen MF, Hwang TL, Hung CF. Human liver regeneration after major hepatectomy. A study of liver volume by computed tomography. Ann Surg 1991;213:227-229.
11. Van Thiel DH, Hagler NG, Schade RR, Skolnick ML, Heyl AP, Rosenblum E, et al. In vivo hepatic volume determination using sonography and computed tomography. Validation and a comparison of the two techniques. Gastroenterology 1985;88:1812-1817.
12. Pandharipande PV, Krinsky GA, Rusinek H, Lee VS. Perfusion imaging of the liver: Current challenges and future goals. Radiology 2005;234:661-673.
13. Zoli M, Magalotti D, Bianchi G, Ghigi G, Orlandini C, Grimaldi M, et al. Functional hepatic flow and Doppler-assessed total hepatic flow in control subjects and in patients with cirrhosis. J Hepatol 1995;23:129-134.
14. Blendis L, Wong F. The hyperdynamic circulation in cirrhosis: An overview. Pharmacol Ther 2001;89:221-231.
15. Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol 1954;30:969-977.
16. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997; 276:60-66.
17. Yoshioka S, Miyazaki M, Shimizu H, Ito H, Nakagawa K, Ambiru S, et al. Hepatic venous hemoglobin oxygen saturation predicts regenerative status of remnant liver after partial hepatectomy in rats. HEPATOLOGY 1998;27: 1349-1353.
18. Shimizu H, Miyazaki M, Yoshioka S, Ito H, Nakagawa K, Ambiru S, et al. Changes in hepatic venous oxygen saturation related to the extent of regeneration after partial hepatectomy in rats. Am J Surg 1999;178:428-431.
19. Barash H, Gross E, Matot I, Edrei Y, Tsarfaty G, Spira G, et al. Functional MR imaging during hypercapnia and hyperoxia: Noninvasive tool for monitoring changes in liver perfusion and hemodynamics in a rat model. Radiology 2007;243:727-735.
20. Ogawa S, Lee TM, Kay AR, Tank DW. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci U S A 1990;87:9868-9872.
21. van Zijl PC, Eleff SM, Ulatowski JA, Oja JM, Ulug AM, Traystman RJ, et al. Quantitative assessment of blood flow, blood volume and blood oxygenation effects in functional magnetic resonance imaging. Nat Med 1998; 4:159-167.
22. Mauad TH, van Nieuwkerk CM, Dingemans KP, Smit JJ, Schinkel AH, Notenboom RG, et al. Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis. Am J Pathol 1994; 145:1237-1245.
23. Popov Y, Patsenker E, Fickert P, Trauner M, Schuppan D. Mdr2 (Abcb4)-/ -mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes. J Hepatol 2005;43:1045-1054.
24. Abramovitch R, Dafni H, Smouha E, Benjamin LE, Neeman M. In vivo prediction of vascular susceptibility to endothelial growth factor withdrawal: Magnetic resonance imaging of C6 rat glioma in nude mice. Cancer Res 1999;59:5012-5016.
25. Higgins GM, Anderson RM. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931;12:186-202.
26. Spira G, Mawasi N, Paizi M, Anbinder N, Genina O, Alexiev R, et al. Halofuginone, a collagen type I inhibitor improves liver regeneration in cirrhotic rats. J Hepatol 2002;37:331-339.
27. Schmidt R, Baechle T, Hoetzel A, Loop T, Humar M, Roesslein M, et al. Dihydralazine treatment limits liver injury after hemorrhagic shock in rats. Crit Care Med 2006;34:815-822.
28. Kobelt F, Schreck U, Henrich HA. Involvement of liver in the decompensation of hemorrhagic shock. Shock 1994;2:281-288.
29. Kwon AH, Matsui Y, Ha-Kawa SK, Kamiyama Y. Functional hepatic volume measured by technetium-99m-galactosyl-human serum albumin liver scintigraphy: Comparison between hepatocyte volume and liver volume by computed tomography. Am J Gastroenterol 2001;96:541-546.
30. Semple SI, Wallis F, Haggarty P, Abramovich D, Ross JA, Redpath TW, et al. The measurement of fetal liver T2* in utero before and after maternal oxygen breathing: Progress towards a non-invasive measurement of fetal oxygenation and placental function. Magn Reson Imaging 2001;19:921-928.
31. Foley LM, Picot P, Thompson RT, Yau MJ, Brauer M. In vivo monitoring of hepatic oxygenation changes in chronically ethanol-treated rats by functional magnetic resonance imaging. Magn Reson Med 2003;50:976-983.
32. Wedegartner U, Tchirikov M, Schafer S, Priest AN, Kooijman H, Adam G, et al. Functional MR imaging: Comparison of BOLD signal intensity changes in fetal organs with fetal and maternal oxyhemoglobin saturation during hypoxia in sheep. Radiology 2006;238:872-880.
33. Abramovitch R, Frenkiel D, Neeman M. Analysis of subcutaneous angiogenesis by gradient echo magnetic resonance imaging. Magn Reson Med 1998;39:813-824.
34. Guyton AC, Hall JE. Textbook of Medical Physiology. St. Louis, MO: W.B. Saunders, 2000.
35. Matot I, Cohen K, Pappo O, Barash H, Abramovitch R. Liver response to hemorrhagic shock and subsequent resuscitation: MRI analysis. Shock 2008;29:16-24.
36. Sato T, El-Assal ON, Ono T, Yamanoi A, Dhar DK, Nagasue N. Sinusoidal endothelial cell proliferation and expression of angiopoietin/Tie family in regenerating rat liver. J Hepatol 2001;34:690-698.
37. Vitellas KM, Tzalonikou MT, Bennett WF, Vaswani KK, Bova JG. Cirrhosis: spectrum of findings on unenhanced and dynamic gadolinium-enhanced MR imaging. Abdom Imaging 2001;26:601-615.
38. Reddy SI, Grace ND. Liver imaging. A hepatologist's perspective. Clin Liver Dis 2002;6:297-310, ix.
39. Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE. Hepatic flow parameters measured with MR imaging and Doppler US: Correlations with degree of cirrhosis and portal hypertension. Radiology 2003;229:409-414.
40. Ben Moshe T, Barash H, Kang TB, Kim JC, Kovalenko A, Gross E, et al. Role of caspase-8 in hepatocyte response to infection and injury in mice. HEPATOLOGY 2007;45:1014-1024.
41. Haliloglu M, Hoffer FA, Gronemeyer SA, Furman WL, Shochat SJ. 3D gadolinium-enhanced MRA: Evaluation of hepatic vasculature in children with hepatoblastoma. J Magn Reson Imaging 2000;11:65-68.
42. Leveille-Webster CR, Rogers J, Arias IM. Use of an asialoglycoprotein receptor-targeted magnetic resonance contrast agent to study changes in receptor biology during liver regeneration and endotoxemia in rats. HEPATOLOGY 1996;23:1631-1641.
43. 31P-MR spectroscopy. HEPATOLOGY 2002; 36:345-353.
44. Debatin JF, Zahner B, Meyenberger C, Romanowski B, Schopke W, Marincek B, et al. Azygos blood flow: Phase contrast quantitation in volunteers and patients with portal hypertension pre- and postintrahepatic shunt placement. HEPATOLOGY 1996;24:1109-1115.
45. Lycklama à Nijeholt GJ, Burggraaf K, Wasser MN, Schultze Kool LJ, Schoemaker RC, Cohen AF, et al. Variability of splanchnic blood flow measurements using MR velocity mapping under fasting and post-prandial conditions - comparison with echo-Doppler. J Hepatol 1997;26:298-304.